Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04774835 · ClinicalTrials.gov registry record · NA

Assisted Partner Services and HIVST in Western Kenya

A NA study of HIV, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
4,941
Enrollment target
1
Study location

NCT04774835: Completed NA study of HIV, sponsored by University of Washington.

NCT04774835 is a NA study of HIV that has completed, run by University of Washington. The registered enrollment target is 4,941 participants, above the 424-participant average among 303 other HIV trials with a reported enrollment target (1065% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04774835, a NA study of HIV, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
4,941 participants
Enrollment target
1
Study location

Study Summary

This study includes different designs with Aim 1 being a cluster randomized controlled trial to investigate the use of HIV self-testing (HIVST) as a mode of HIV testing in Western Kenya in addition to the standard of care, assisted partner services (aPS). Aim 2 includes focus group discussions, in-depth interviews, semi-structured interviews, direct observation of facility infrastructure and clinic procedures, and data extraction from facility and county/national databases and expenditure reports to study acceptability, costs, and implementation aspects of HIVST within the aPS framework.

Primary Outcome

Identify if there's a difference between standard aPS and aPS+HIVST in the number of participants choosing to get HIV tested for the first time.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST HIVST
  • DIAGNOSTIC_TEST Standard aPS

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 4,941 participants
Start Date 2021-03-01
Est. Completion 2022-10-12
Phase NA
University of Washington

1,048 total trials

What the finished NCT04774835 record still lists

NCT04774835 is an interventional study that assigns participants to a tested intervention. Its 4,941 participants enrollment target places it among the larger protocols in the corpus, above the 424-participant average among 303 other HIV trials with a reported enrollment target (1065% higher).

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 2 interventions - of which HIVST is the first listed.

NCT04774835 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT04774835 about?

NCT04774835 is a clinical study titled "Assisted Partner Services and HIVST in Western Kenya". This study includes different designs with Aim 1 being a cluster randomized controlled trial to investigate the use of HIV self-testing (HIVST) as a mode of HIV testing in Western Kenya in addition to the standard of care, assisted partner services (aPS). Aim 2 includes focus group discussions, in-d...

What is the current status of trial NCT04774835?

This trial is currently completed. It is a NA study. The enrollment target is 4,941 participants. The study started on 2021-03-01. Estimated completion is 2022-10-12.

What conditions does trial NCT04774835 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT04774835?

The interventions under investigation include: HIVST (DIAGNOSTIC_TEST), Standard aPS (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04774835?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04774835 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04774835's enrollment target sits among peer trials

4,941 5th of 303 higher than 299 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05929976 · 4,900 participants

    InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort

  • NCT00060541 · 5,000 participants

    Evaluation and Treatment of Neurosurgical Disorders

  • NCT00575081 · 5,000 participants

    Physiological Brain Atlas Development

  • NCT00736749 · 5,000 participants

    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04774835, the US trial registry maintained by the National Library of Medicine. NCT04774835 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.